Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells - PubMed (original) (raw)
. 2008 Feb 15;103(3):800-11.
doi: 10.1002/jcb.21449.
Affiliations
- PMID: 17614351
- DOI: 10.1002/jcb.21449
Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells
Ana C Donadio et al. J Cell Biochem. 2008.
Abstract
Glutamine behaves as a key nutrient for tumors and rapidly dividing cells. Glutaminase is the main glutamine-utilizing enzyme in these cells, and its activity correlates with glutamine consumption and growth rate. We have carried out the antisense L-type glutaminase inhibition in human MCF7 breast cancer cells, in order to study its effect on the hexosamine pathway and the pattern of protein O-glycosylation. The antisense mRNA glutaminase expressing cells, named ORF19, presented a 50% lower proliferation rate than parental cells, showing a more differentiated phenotype. ORF19 cells had an 80% reduction in glutamine:fructose-6-P amidotransferase activity, which is the rate-limiting step of the hexosamine pathway. Although the overall cellular protein O-glycosylation did not change, the O-glycosylation status of several key proteins was altered. O-glycosylation of O-GlcNAc transferase (OGT), the enzyme that links N-acetylglucosamine to proteins, was fivefold lower in ORF19 than in wild type cells. Inhibition of glutaminase also provoked a 10-fold increase in Sp1 expression, and a significant decrease in the ratio of O-glycosylated to total protein for both Sp1 and the Rpt2 proteasome component. These changes were accompanied by a higher Sp1 transcriptional activity. Proteome analysis of O-glycosylated proteins permitted the detection of two new OGT target proteins: the chaperonin TCP-1 theta and the oncogene Ets-related protein isoform 7. Taken together, our results support the hexosamine pathway and the O-glycosylation of proteins being a sensor mechanism of the nutritional and energetic states of the cell.
Copyright 2007 Wiley-Liss, Inc.
Similar articles
- Inhibition of glutaminase expression increases Sp1 phosphorylation and Sp1/Sp3 transcriptional activity in Ehrlich tumor cells.
Segura JA, Donadio AC, Lobo C, Matés JM, Márquez J, Alonso FJ. Segura JA, et al. Cancer Lett. 2005 Jan 31;218(1):91-8. doi: 10.1016/j.canlet.2004.06.054. Cancer Lett. 2005. PMID: 15639344 - Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
Dauphinee SM, Ma M, Too CK. Dauphinee SM, et al. J Cell Biochem. 2005 Oct 15;96(3):579-88. doi: 10.1002/jcb.20508. J Cell Biochem. 2005. PMID: 16052526 - Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
Liu J, Marchase RB, Chatham JC. Liu J, et al. J Mol Cell Cardiol. 2007 Jan;42(1):177-85. doi: 10.1016/j.yjmcc.2006.09.015. Epub 2006 Oct 27. J Mol Cell Cardiol. 2007. PMID: 17069847 Free PMC article. - Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
Chatham JC, Nöt LG, Fülöp N, Marchase RB. Chatham JC, et al. Shock. 2008 Apr;29(4):431-40. doi: 10.1097/shk.0b013e3181598bad. Shock. 2008. PMID: 17909453 Review. - Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG. Buse MG. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. doi: 10.1152/ajpendo.00329.2005. Am J Physiol Endocrinol Metab. 2006. PMID: 16339923 Free PMC article. Review.
Cited by
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.
DeBerardinis RJ, Cheng T. DeBerardinis RJ, et al. Oncogene. 2010 Jan 21;29(3):313-24. doi: 10.1038/onc.2009.358. Epub 2009 Nov 2. Oncogene. 2010. PMID: 19881548 Free PMC article. Review. - Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells.
Szeliga M, Bogacińska-Karaś M, Różycka A, Hilgier W, Marquez J, Albrecht J. Szeliga M, et al. Tumour Biol. 2014 Mar;35(3):1855-62. doi: 10.1007/s13277-013-1247-4. Epub 2013 Oct 6. Tumour Biol. 2014. PMID: 24096582 Free PMC article. - The role of protein O-linked beta-N-acetylglucosamine in mediating cardiac stress responses.
Chatham JC, Marchase RB. Chatham JC, et al. Biochim Biophys Acta. 2010 Feb;1800(2):57-66. doi: 10.1016/j.bbagen.2009.07.004. Epub 2009 Jul 14. Biochim Biophys Acta. 2010. PMID: 19607882 Free PMC article. Review. - Distribution of selenium and oxidative stress in breast tumor-bearing mice.
Guo CH, Hsia S, Chen PC. Guo CH, et al. Nutrients. 2013 Feb 20;5(2):594-607. doi: 10.3390/nu5020594. Nutrients. 2013. PMID: 23429470 Free PMC article. - O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA, Chen W, Bond MR. Hanover JA, et al. J Bioenerg Biomembr. 2018 Jun;50(3):155-173. doi: 10.1007/s10863-018-9751-2. Epub 2018 Mar 29. J Bioenerg Biomembr. 2018. PMID: 29594839 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous